Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Nov 21;12(12):1646.
doi: 10.3390/antibiotics12121646.

Performance and Impact on Antibiotic Prescriptions of a Multiplex PCR in a Real-Life Cohort of Critically Ill Patients with Suspected Ventilated Pneumonia: A Retrospective Monocentric Observational Study

Affiliations

Performance and Impact on Antibiotic Prescriptions of a Multiplex PCR in a Real-Life Cohort of Critically Ill Patients with Suspected Ventilated Pneumonia: A Retrospective Monocentric Observational Study

Emma Chambe et al. Antibiotics (Basel). .

Abstract

Pulmonary multiplex polymerase chain reaction (m-PCR) allows rapid pathogen detection. We aimed to assess its impact on initial antibiotic prescriptions in ventilated patients with suspected pneumonia. Between November 2020 and March 2022,ventilated patients with suspected pneumonia hospitalized in our ICU who benefited from respiratory sampling simultaneously tested using conventional microbiological methods and m-PCR were included. The proportion of appropriate changes in the initial antibiotic therapy following m-PCR results was assessed. We analyzed 104 clinical samples. Of the 47 negative m-PCR results, 16 (34%) led to an appropriate antibiotic strategy: 8 cessationsand 8 lack of initiation. Of the 57 positive m-PCR results, 51 (89%) resulted in an appropriate antibiotic strategy: 33 initiations, 2 optimizations, and 9 de-escalations. In the multivariate analysis, a positive m-PCR was associated with an appropriate antibiotic change (OR: 96.60; IC95% [9.72; 960.20], p < 0.001). A higher SAPS II score was negatively associated with an appropriate antibiotic change (OR: 0.96; IC95% [0.931; 0.997], p = 0.034). In our cohort, a positive m-PCR allowed for early initiation or adjustment of antibiotic therapy in almost 90% of cases. A negative m-PCR spared antibiotic use in onethird of cases. The impact of m-PCR results was reduced in the most severe patients.

Keywords: COVID-19; antibiotic use; intensive care; multiplex PCR; pneumonia.

PubMed Disclaimer

Conflict of interest statement

A.M. received speaking fees from BioMerieux. Other authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Study flowchart.
Figure 2
Figure 2
Antibiotic prescriptions after m-PCR and conventional culture results: (A) In case of negative PCR and (B) In case of positive PCR.
Figure 2
Figure 2
Antibiotic prescriptions after m-PCR and conventional culture results: (A) In case of negative PCR and (B) In case of positive PCR.

References

    1. Rosenthal V.D., Al-Abdely H.M., El-Kholy A.A., AlKhawaja S.A.A., Leblebicioglu H., Mehta Y., Rai V., Hung N.V., Kanj S.S., Salama M.F., et al. International nosocomial infection control consortium report, data summary of 50 countries for 2010-2015: Device-associated module. Am. J. Infect. Control. 2016;44:1495–1504. doi: 10.1016/j.ajic.2016.08.007. - DOI - PubMed
    1. Ohannessian R., Gustin M.-P., Bénet T., Gerbier-Colomban S., Girard R., Argaud L., Rimmelé T., Guerin C., Bohé J., Piriou V., et al. Estimation of extra length of stay attribuable to hospital-acquired infections in adult ICUs using a time-dependent multistate model. Crit. Care Med. 2018;46:1093–1098. doi: 10.1097/CCM.0000000000003131. - DOI - PubMed
    1. Melsen W.G., Rovers M.M., Groenwold R., Bergmans D.C., Camus C., Bauer T.T., Hanisch E., Klarin B., Koeman M., Krueger W.A., et al. Attribuable mortality of ventilator-associated pneumonia: Ameta-analysis of individual patient data from randomised prevention studies. Lancet Infect. Dis. 2013;13:665–671. doi: 10.1016/S1473-3099(13)70081-1. - DOI - PubMed
    1. Zhu N., Zhang D., Wang W., Li X., Yang B., Song J., Zhao X., Huang B., Shi W., Lu R., et al. A novel coronavirus from patients with pneumonia in China, 2019. N. Engl. J. Med. 2020;382:727–733. doi: 10.1056/NEJMoa2001017. - DOI - PMC - PubMed
    1. Huang C., Wang Y., Li X., Ren L., Zhao J., Hu Y., Zhang L., Fan G., Xu J., Gu X., et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497–506. doi: 10.1016/S0140-6736(20)30183-5. - DOI - PMC - PubMed

LinkOut - more resources